International impact
Research undertaken at the Sheffield CTRU has had an impact on the care of patients and the organisation of healthcare services internationally. The list below includes studies that have impacted international health policy.
CACTUS
Computerised assisted language therapy pilot study
International impact
Health technology assessment of chronic disease self-management support interventions (Ireland)
Rééducation à la phase chronique d’un AVC de l’adulte: Pertinence, indications et modalités (France)
REEACT
The Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy
View REEACT summary (University of York)
International impact
Therapist-supported internet therapy for mental disorders – a health technology assessment (Norway)
SABRE
Hypertonic Saline in Acute Bronchiolitis: A Randomised Controlled Trial and Economic Evaluation
International impact
Nebulized Hypertonic Saline for Asthma in Adults and Children: Clinical Effectiveness (Canada)
Alahengitystieinfektiot (Finland)
Prise en charge du 1er épisode de bronchiolite aiguë chez le nourrisson de moins de 12 mois (France)
HUbBLe
Haemorrhoidal Artery Ligation (HAL) versus Rubber Band Ligation (RBL) for haemorrhoids
International impact
REPOSE
Relative Effectiveness of Pumps over MDI and Structured Education for Type-1 Diabetes
International impact
Insulin Pumps for Patients with Any Diabetes Type: Clinical Effectiveness and Guidelines (Canada)
DiPALS
A Randomised Controlled Trial Evaluating NeuRx/4 Diaphragm Pacing in Patients with Respiratory Muscle Weakness Due to Motor Neurone Disease
International impact
Big CACTUS
A study to assess the clinical and cost effectiveness of aphasia computer treatment versus usual stimulation or attention control long-term post-stroke (CACTUS)
International impact
Rééducation à la phase chronique de l’AVC de l’adulte: pertinence, indications et modalités (France)
PRIEST
Pandemic Respiratory Infection Emergency System Triage]
International impact
Clinical management of COVID-19: living guideline (World Health Organisation)
OPTION-DM
Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus trial